<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2015-07-30 13:12:07Blood Coagulation system Biology Recombinant proteins Baxalta Von Willebrand disease Haemophilia Factor VIII PEGylation Baxter International Factor VII Recombinant factor VIIa |
|
UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A •